Company Number: 15432298

Analysis Date: 2025-07-20 16:16 UTC

Financial Health Assessment of Avance Innovations Ltd as of 31 December 2024

---

1. Financial Health Score: D (At Risk)

Explanation:
Avance Innovations Ltd shows significant early-stage financial strain indicated by negative net assets and net current liabilities. While this is not uncommon for a newly incorporated company in its first year, these "symptoms" suggest distress that requires close monitoring and immediate corrective action to avoid worsening financial health.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Liabilities	102,836	Debts due within one year; relatively significant compared to total assets (likely minimal).
Net Current Assets	-102,836	Negative working capital ("symptom of liquidity stress"); company owes more short-term than it owns.
Total Assets Less Current Liabilities	-102,836	Indicates total net assets are negative; company’s liabilities exceed assets.
Net Assets (Shareholders’ Funds)	-103,686	Negative equity ("symptom of financial distress"); shareholders’ funds are eroded.
Average Number of Employees	1	Micro entity with minimal payroll obligations, reducing operating expenses for now.

Additional Context:

• Company Size & Category: Micro entity, which means minimal filing requirements and likely early-stage operations.
• Industry: Manufacture of medical and dental instruments — a capital-intensive sector where initial investments and costs may be high.
• Ownership: Single director and sole shareholder (Ankur Khajuria) with full control.
• No overdue filings or compliance issues.

---

3. Diagnosis

The financial "vital signs" reveal that Avance Innovations Ltd is currently in a fragile financial state, characterized by:

• Negative working capital: The company owes significantly more in short-term liabilities than it holds in short-term assets. This indicates a potential cash flow crunch, meaning the company might struggle to meet immediate financial obligations without additional funding or revenue inflows.

• Negative net assets: The company’s total liabilities exceed total assets, leading to negative shareholders’ equity. This often reflects initial startup losses or investments funded by shareholder loans or external creditors.

• Early-stage status: Incorporated in January 2024, the company has had less than a year of trading activity, which explains the absence of accumulated profits. Negative equity at this stage can be typical but must be addressed to avoid insolvency symptoms.

• Micro-entity scale: With only one employee (the director) and minimal operational scale, the company likely has limited revenue generation so far.

Underlying Business Health Insight:
The company is in a vulnerable "pre-symptomatic" phase typical of startups—investing heavily upfront with little revenue yet. However, without a clear path to improving liquidity and reversing negative equity, the risk of financial distress and insolvency grows.

---

4. Prognosis

• Short-term outlook: The company must secure additional working capital to cover immediate liabilities or quickly generate operating cash flow. Failure to do so may lead to liquidity crisis ("cash flow arrest") and possible insolvency procedures.

• Medium to long-term outlook: If the company can develop its product line, attract customers, and manage costs prudently, it may recover financial health as revenues grow. However, ongoing losses will deepen negative equity and complicate financing.

---

5. Recommendations

1. Immediate Cash Flow Management:

   • Seek infusion of funds via shareholder loans, equity injection, or short-term credit facilities to cover current liabilities.
   • Negotiate payment terms with creditors to extend due dates if possible.

2. Detailed Cash Flow Forecasting:

   • Prepare rolling cash flow projections to anticipate liquidity gaps.
   • Identify timing of cash inflows and outflows to manage working capital proactively.

3. Cost Control Measures:

   • Minimize discretionary spending and delay non-essential capital expenditures.
   • Monitor payroll and supplier costs carefully given micro-entity scale.

4. Revenue Generation Strategy:

   • Accelerate product development and market entry plans.
   • Explore early customer engagement, pre-orders, or partnerships to generate initial revenue streams.

5. Engage Professional Advice:

   • Consult with financial advisors or insolvency practitioners for restructuring options if cash flow issues persist.
   • Consider periodic financial reviews to track improvement or signs of deterioration.

6. Governance and Reporting:

   • Maintain timely filing of accounts and confirmation statements to avoid regulatory penalties.
   • Keep transparent and updated records for stakeholder confidence.

---

Summary

Avance Innovations Ltd currently exhibits classic "startup distress" symptoms with negative working capital and net assets indicating financial strain. While typical for a new company, these signs demand proactive cash flow management and strategic focus to avoid worsening liquidity problems. With prompt corrective action and effective execution of growth plans, the company may stabilize and improve its financial health.